Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy
NCT06419140
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
138
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
Standard SOX/XELOX adjuvant chemotherapy plus multimodal rehabilitation
Sponsor
Zhejiang Cancer Hospital